Amplitude Vascular Systems wins FDA IDE approval for intravascular lithotripsy study
June 6, 2024
Amplitude Vascular Systems announced today that it received FDA investigational device exemption (IDE) for its pulsatile intravascular lithotripsy (PIVL) therapy.
